Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

Clinical trial NCT05399537 · RECRUITING

Trial details

NCT number: NCT05399537
Sponsor: Vantive Health LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Regional Citrate Anticoagulation (RCA)Continuous Renal Replacement Therapy (CRRT)Acute Kidney Injury (AKI)

Start date: 2024-07-12
Primary completion: 2026-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.